Drug Channels

JULY 12, 2022

pharmacy industry—now act as contract pharmacies for the hospitals and other healthcare providers that participate in the 340B program. For more on 340B and the specialty market, join me for my upcoming July 29 live video webinar, Specialty Drugs Update: Trends, Controversies, and Outlook. Read on for details and my commentary below.

Pharmacy 98

Pharmacy Marketing Hospitals Drugs 98

Drug Channels

JUNE 12, 2024

The 340B contract pharmacy market shows little sign of slowing down. Drug Channels Institute’s exclusive analysis of the 2024 market reveals that: About 33,000 pharmacy locations—more than half of the entire U.S. pharmacy industry—act as contract pharmacies for the hospitals and federal grantees that participate in the 340B program.

Pharmacy 52

Pharmacy Specialty Pharmacies Hospitals Marketing 52

Drug Channels

OCTOBER 2, 2024

The 340B contract pharmacy market shows little sign of slowing down. Drug Channels Institute’s exclusive analysis of the 2024 market reveals that: About 33,000 pharmacy locations—more than half of the entire U.S. pharmacy industry—act as contract pharmacies for the hospitals and federal grantees that participate in the 340B program.

Pharmacy 52

Pharmacy Specialty Pharmacies Hospitals Marketing 52

Drug Channels

JUNE 3, 2020

Consistent with our previous analyses, the share of pharmacists who work at hospitals reached a new high. Average base salaries were about $125,000, though there was substantial variation across practice settings. Total pharmacist employment grew in 2019. However, the number of pharmacists working in retail settings decreased.

Hospitals 52

Hospitals Marketing Pharmacy Drugs 52

Perficient: Drug Development

DECEMBER 13, 2023

This year, Perficient is thrilled to return as the primary sponsor of the “Light Up Glennon” event at SSM Health Cardinal Glennon Children’s Hospital , in which our colleagues along with the entire St. Come join Perficient as we shine our lights toward the hospital, ring in the holidays, and bring happiness to children.

Hospitals 59

Hospitals Marketing 59

Drug Channels

JULY 11, 2023

pharmacy industry—act as contract pharmacies for the hospitals and other healthcare providers that participate in the 340B program. Manufacturers’ contract pharmacy policy changes have slowed profits at pharmacies and PBMs, while triggering change in hospitals’ pharmacy strategies. d/b/a Drug Channels Institute.

Pharmacy 74

Pharmacy Marketing Hospitals Drugs 74

Perficient: Drug Development

OCTOBER 8, 2024

One shining example is our recruitment strategy for Bayhealth, which was recently featured by the online publication, Strategic Health Care Marketing. Recognizing the need for a unified front, our team emphasized the importance of collaboration between HR and marketing.

Marketing 52

Marketing Testimonials Hospitals Science 52

Drug Channels

APRIL 4, 2024

For updated data on hospital-owned specialty pharmacies, see Chapter 3 of DCI's new 2024 Economic Report on U.S. As many of you know, hospitals and health systems have emerged as significant participants in the specialty pharmacy industry. I then highlight how hospitals steer prescriptions to their internal specialty pharmacies.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Hospitals International 52

Drug Channels

JUNE 8, 2021

We have found that the share of pharmacists who work at hospitals reached a new high. What’s more, average base salaries for retail pharmacists have dropped, while salaries have risen for pharmacists employed by hospitals, physician offices, and other non-retail settings. .

Hospitals 40

Hospitals Marketing Drugs Pharmacy 40

Predictive Oncology

JULY 24, 2024

Read our white paper below that details the multi-year study conducted with UPMC Magee-Women’s Hospital. The post Predictive Oncology enters biomarker discovery market after successful retrospective ovarian cancer study yields compelling results appeared first on Predictive Oncology. Please fill out the form below.

Marketing 52

Marketing Hospitals Drugs 52

Drug Channels

MAY 9, 2023

Last week, Paula and I had the pleasure of attending Asembia’s 2023 Specialty Pharmacy Summit at the wonderful Wynn Las Vegas. As I do every year, I will violate Vegas code and tell you what happened there.

Specialty Pharmacies 98

Specialty Pharmacies Marketing Pharmacy Drugs 98

Drug Channels

APRIL 12, 2023

For 2022, pharmacy benefits managers (PBMs) and insurers expanded their dominance over specialty dispensing, though both hospitals and physician practices are growing their share of the market. As predicted last year, Walgreens’ specialty pharmacy business has collapsed, which led to a slightly less concentrated industry.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Independent Pharmacies Hospitals 98

Drug Channels

AUGUST 6, 2024

I then document how five multi-billion-dollar, for-profit, publicly traded pharmacy chains and pharmacy benefit managers (PBMs)—Cigna (via Express Scripts), CVS Health, UnitedHealth Group (via OptumRx), and Walgreens, Walmart—continue to dominate the 340B contract pharmacy market. Click here if you can’t see the video below.

Pharmacy 90

Pharmacy Hospitals Marketing Drugs 90

Drug Channels

JUNE 18, 2024

One important update to the figures below: We (and many others) had significantly underestimated Walgreens' revenues and market share. Consequently, its market share is closer to 10%, compared with the 3% that we reported. billion figure was roughly accurate for the AllianceRx Walgreens Pharmacy business. All rights reserved.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Marketing Hospitals 52

Drug Target Review

APRIL 14, 2025

The antibiotic market has long faced significant barriers to innovation, with structural issues that make it difficult for new antibiotics to gain traction. As the demand for novel antibiotics remains limited due to the preference for cheaper generics, the market has struggled to incentivise much-needed breakthroughs.

Therapies 52

Therapies Marketing Drug Development Treatment 52

Perficient: Drug Development

OCTOBER 16, 2023

The healthcare landscape is ever evolving, and as marketers, it’s essential to stay ahead of the curve. Marketers especially feel the brunt of this, striving to optimize their strategies amidst these challenges and seamlessly bridge the gaps in connection, care, and convenience for their audiences.

Marketing 52

Marketing Government Hospitals 52

The Pharma Data

JANUARY 11, 2021

Collaboration agreement with Neurosurgery Department of Karolinska University Hospital will further enhance the usage of the company’s transformative IRRAflow system to benefit neurocritical care patients in Sweden. About Karolinska University Hospital. STOCKHOLM , Jan. STOCKHOLM , Jan. About IRRAS.

Hospitals 40

Hospitals International Production Treatment 40

Drug Channels

SEPTEMBER 13, 2022

These include disruption to the now-booming biosimilar market, the prospects of physician/hospital vertical integration that will raise commercial healthcare costs and expand 340B, and the need for complex new processes to administer the IRA's lower pharmacy reimbursements.

Biosimilars 97

Biosimilars Pharmacy Hospitals Marketing 97

Drug Channels

AUGUST 8, 2023

on the overall market, explained channel distortions from 340B contract pharmacies, and offered some policy recommendations. Recently, a bipartisan group of six U.S. Click here to read the full letter. I submitted a 14-page letter, which you can read below. I shared my $0.02 How could I not?

Pharmacy 96

Pharmacy Hospitals Drugs Pharmaceuticals 96

Drug Channels

DECEMBER 12, 2022

These include disruption to the now-booming biosimilar market, the prospects of physician/hospital vertical integration that will raise commercial healthcare costs and expand 340B, and the need for complex new processes to administer the IRA's lower pharmacy reimbursements.

Biosimilars 98

Biosimilars Pharmacy Hospitals Marketing 98

Drug Channels

MAY 18, 2021

However, pharmacy locations owned by healthcare providers—hospitals, health systems, physician practices, and providers’ group purchasing organizations—now account for nearly 40% of all accredited specialty pharmacy locations. Overall accreditation growth appears to be slowing. Read on for a bite of our arithmomania.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Marketing Hospitals 52

Drug Channels

SEPTEMBER 15, 2021

I want to share with you, dear reader, the strange but true tale of my recent foray into the wonderful world of hospital price transparency for routine lab services. Sometimes, a little knowledge can be a bad thing. to 1:30 p.m. CLICK HERE TO LEARN MORE AND SIGN UP. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc.

Hospitals 75

Hospitals Regulations Marketing Drugs 75

The Pharma Data

AUGUST 19, 2021

Designed for hospitals as well as outpatient and ASC settings where economic value and operational efficiency are critical considerations. The INHANCE Shoulder System reflects our strong commitment to lead in shoulder arthroplasty by taking innovation to the next level.”.

Marketing 52

Marketing Treatment Hospitals Production 52

The Pharma Data

DECEMBER 17, 2020

(NASDAQ: REGN ) today announced that the New England Journal of Medicine (NEJM) has published initial clinical data from an ongoing seamless Phase 1/2/3 trial of the antibody cocktail casirivimab and imdevimab in non-hospitalized patients with COVID-19. “The investigational cocktail is now available to indicated high-risk U.S.

Hospitals 52

Hospitals Production Clinical Trials Virus 52

The Pharma Data

NOVEMBER 5, 2020

Regeneron announced today an update from the independent data monitoring committee (DMC) for the United Kingdom-based RECOVERY trial evaluating REGN-COV2 in hospitalized patients with COVID-19.

Hospitals 52

Hospitals Trials Clinical Trials Production 52

Drug Channels

MAY 25, 2021

P.S. Join the nearly 11,800 followers of my daily links to neat stuff at @DrugChannels on Twitter.

Hospitals 40

Hospitals Pharmacy Drugs Marketing 40

The Pharma Data

OCTOBER 19, 2020

(OTCQB: BRSF ), a neurology-focused medical device and software company, today announced the appointment of Stuart Bernstein as Vice President of Marketing. In this role, Bernstein will be responsible for Brain Scientific’s overall marketing strategy and efforts to strengthen the company’s market position.

Marketing 40

Marketing Engineering Production Government 40

The Pharma Data

JUNE 22, 2023

Kite Announces Completion of Marketing Authorization Transfer for Yescarta® CAR T-cell Therapy in Japan SANTA MONICA, Calif.–(BUSINESS in December 2022 about changes to their initial 2017 partnership whereby Daiichi Sankyo obtained the Marketing Authorization for Yescarta ®. –(BUSINESS WIRE)– Kite Pharma, Inc.,

Therapies 40

Therapies Marketing Small Molecule Science 40

Drug Channels

MARCH 15, 2022

Prescription Market (press release) We’re offering special discounted pricing if you order before March 28, 2022. As always, we have updated all market and industry data with the most current information available, including our annual analyses of the market positions of the largest pharmacies, specialty pharmacies, and PBMs.

Pharmacy 98

Pharmacy Specialty Pharmacies Licensing Licensing 98

The Pharma Data

OCTOBER 30, 2020

(NASDAQ: REGN) received today a recommendation from the independent data monitoring committee (IDMC) for the REGN-COV2 antibody cocktail treatment trials for COVID-19 that the current hospitalized patient trial be modified. About the REGN-COV2 Trial in Hospitalized Patients. Cohort 1A: patients not requiring oxygen.

Hospitals 52

Hospitals Virus Production Clinical Trials 52

Broad Institute

OCTOBER 23, 2024

When Emma’s feeling good she exudes this happiness to her, but she does have immense health challenges,” said her father, Brian Broadbent, a digital marketing executive in Dallas, Texas, who’s raising Emma and her sister, Claire, with his wife, Julia.

DNA 128

DNA RNA Disease Hospitals 128

Conversations in Drug Development Trends

OCTOBER 14, 2024

For patients with autoimmune diseases, these new therapies mean fewer hospitalizations, less pain, and more days where they can live a normal life without debilitating symptoms. How Our Global Network and Innovation Impacts Patients’ Lives The importance of these innovations cannot be overstated.

Research 52

Research Clinical Trials Therapies Immune Response 52

Agency IQ

JANUARY 4, 2024

Swissmedic reorg adds new focus on medical device market surveillance The Swiss regulator, Swissmedic, just announced a reorganization, with a new head of the medicinal product authorization and vigilance sector, but also a new and discrete medical devices surveillance sector. KAROLINE MATHYS is the head of the new sector.

Marketing 40

Marketing Regulations Clinical Trials International 40

PPD

OCTOBER 17, 2024

There has also been an increase in government and regulatory support for CGT trials, in conjunction with an increase in investments for these products to get to market. To find success among the competition, sponsors must have access to the necessary expertise and resources to approach this burgeoning market.

Therapies 97

Therapies Clinical Trials Clinical Research Trials 97

Drug Channels

SEPTEMBER 9, 2020

In May, I recorded a brief video webinar for an on-demand business education session at Asembia's 2020 Specialty Pharmacy Summit Virtual Experience. You can watch the full video below.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Marketing Drugs 52

Drug Channels

OCTOBER 5, 2021

This 2021-22 edition contains the most current financial and industry data along with detailed information about the strategies and market positions of the largest companies: AmerisourceBergen, Cardinal Health, and McKesson. reviews AmerisourceBergen’s entry into the European distribution market. (We Section 4.4. Section 7.4.4.

Pharmaceuticals 75

Pharmaceuticals Biosimilars Licensing Licensing 75

The Pharma Data

DECEMBER 3, 2020

In addition, CMS assigned the new HCPCS codes to Ambulatory Payment Classifications (APCs) that determine hospital outpatient payment. These codes will be effective January 1, 2021. Starting in January 2021, there will now be four codes that pertain to below-the-knee IVL procedures and four that pertain to above-the-knee IVL procedures.

Hospitals 40

Hospitals Production Clinical Trials Disease 40